Organisation paid for research Program year 2025 Source: CMS Open Payments

KMW, Inc

Neither a doctor nor a teaching hospital

Research payments

$262,954

54 payments

Through program year 2025, KMW, Inc is reported as receiving $262,954 in research payments, across 54 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$27,244	8
2024	Research	$23,327	8
2023	Research	$100,518	11
2022	Research	$107,530	26
2021	Research	$4,335	1

Breakdown

Who paid Research payments · program years 2021–2025

Ascendis Pharma, Inc. $140,060 31 payments
Senseonics, Incorporated $80,306 5 payments
CSL Behring $42,588 18 payments

Studies the money was for Research payments · program years 2021–2025

PaTHway TRIAL $98,745 16 payments
Senseonics CTP0034 PAS $63,856 3 payments
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Proof of Concept Study of Vascular Endothelial Growth Factor (VEGF)-B Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease $42,588 18 payments
PaTHway TRIAL $27,244 8 payments
PaTHway $14,071 7 payments
Senseonics CTP0034 $9,256 1 payment
Senseonics CTP0039 PAS $7,194 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.